Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...
A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...
STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced its participation at upcoming mRNA ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback